Burgard; Edward C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Burgard; Edward C..The latest application filed is for "compositions for inducing urinary voiding and defecation".

Company Profile

1.7.26

Burgard; Edward C. - Research Triangle Park NC
Burgard; Edward C. - Chapel Hill NC
Burgard; Edward C. - Libertyville IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions for inducing urinary voiding and defecation Grant 11,352,391 - Ricca , et al. June 7, 2	2022-06-07
Compositions For Inducing Urinary Voiding And Defecation App 20200262868 - RICCA; Daniel Joseph ; et al.	2020-08-20
Pharmaceutical Composition For Treating Or Preventing Stress Urinary Incontinence Or Mixed Urinary Incontinence, And Method For Screening Compound Comprised In Said Pharmaceutical Composition App 20150368220 - Watanabe; Toru ; et al.	2015-12-24
METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING alpha2delta SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS App 20110294881 - Fraser; Matthew Oliver ; et al.	2011-12-01
Methods Of Treating Non-painful Bladder Disorders Using Alpha2delta Subunit Calcium Channel Modulators App 20090203792 - Thor; Karl Bruce ; et al.	2009-08-13
Methods of using ziconotide to treat overactive bladder Grant 7,459,430 - Fraser , et al. December 2, 2	2008-12-02
Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulators App 20080275080 - Fraser; Matthew Oliver ; et al.	2008-11-06
Methods For Treating Lower Urinary Tract Disorders Using Alpha2delta Subunit Calcium Channel Modulators With Smooth Muscle Modulators App 20080085916 - Fraser; Matthew Oliver ; et al.	2008-04-10
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders Grant 7,223,754 - Fraser , et al. May 29, 2	2007-05-29
Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators App 20070105785 - Fraser; Matthew Oliver ; et al.	2007-05-10
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders App 20070066597 - Fraser; Matthew Oliver ; et al.	2007-03-22
Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators App 20070060652 - Fraser; Matthew Oliver ; et al.	2007-03-15
Methods for treating functional bowel disorders using alpha2 subunit calcium channel modulators with smooth muscle modulators App 20060276542 - Fraser; Matthew Oliver ; et al.	2006-12-07
Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators App 20060247311 - Fraser; Matthew Oliver ; et al.	2006-11-02
Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators Grant 7,125,848 - Fraser , et al. October 24, 2	2006-10-24
Methods of using ziconotide to treat overactive bladder App 20060234939 - Fraser; Matthew Oliver ; et al.	2006-10-19
Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators App 20060188575 - Thor; Karl Bruce ; et al.	2006-08-24
Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Ca.sub.v2.2 subunit calcium channel modulators Grant 7,084,116 - Fraser , et al. August 1, 2	2006-08-01
Methods of treating gastrointestinal tract disorders using sodium channel modulators Grant 7,041,704 - Burgard , et al. May 9, 2	2006-05-09
Methods for decreasing detrusor muscle overactivity App 20050239890 - Fraser, Matthew Oliver ; et al.	2005-10-27
Methods for decreasing detrusor App 20050228049 - Thor, Karl Bruce ; et al.	2005-10-13
Methods of treating gastrointestinal tract disorders using sodium channel modulators App 20050203190 - Burgard, Edward C. ; et al.	2005-09-15
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders App 20050148587 - Fraser, Matthew Oliver ; et al.	2005-07-07
Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders App 20050113421 - Fraser, Matthew Oliver ; et al.	2005-05-26
Methods of treating lower urinary tract disorders using losigamone App 20050107353 - Burgard, Edward C. ; et al.	2005-05-19
Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators App 20050054725 - Thor, Karl Bruce ; et al.	2005-03-10
Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators App 20050026835 - Fraser, Matthew Oliver ; et al.	2005-02-03
Methods of treating gastrointestinal tract disorders using sodium channel modulators App 20040213842 - Burgard, Edward C. ; et al.	2004-10-28
Methods of treating lower urinary tract disorders using sodium channell modulators App 20040209960 - Burgard, Edward C. ; et al.	2004-10-21
Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators App 20040198775 - Fraser, Matthew Oliver ; et al.	2004-10-07
Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators App 20040198822 - Fraser, Matthew Oliver ; et al.	2004-10-07
Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators App 20040142034 - Thor, Karl Bruce ; et al.	2004-07-22
Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof Grant 6,242,216 - Lynch , et al. June 5, 2	2001-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.